These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage. Abendroth D; Capalbo M; Illner WD; Landgraf R; Land W Transplant Proc; 1992 Jun; 24(3):786-7. PubMed ID: 1376524 [No Abstract] [Full Text] [Related]
10. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO Transplant Proc; 1994 Apr; 26(2):531-3. PubMed ID: 7513455 [No Abstract] [Full Text] [Related]
11. Monitoring of renal allograft rejection with fine needle aspiration biopsy and serum C-reactive protein determinations. Kaden J; Strobelt V; Oesterwitz H; Groth J; May G; Eichler C Transplant Proc; 1987 Feb; 19(1 Pt 2):1657. PubMed ID: 3274398 [No Abstract] [Full Text] [Related]
12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
13. Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. Cooper JE; Wiseman AC; Chan L Clin Transpl; 2009; ():455-9. PubMed ID: 20524314 [No Abstract] [Full Text] [Related]
14. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve. Yilmaz S; Kallio E; Yilmaz A; Häyry P Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233 [No Abstract] [Full Text] [Related]
15. Correlation between duodenal and kidney rejection: a histologic comparative study in a pig model of pancreaticoduodenal-kidney transplantation. Gruessner RW; Nakhleh R; Tzardis PJ; Schechner R; Troppmann C; Gruessner AC; Najarian JS; Sutherland DE Transplant Proc; 1994 Apr; 26(2):541-3. PubMed ID: 8171544 [No Abstract] [Full Text] [Related]
16. Percutaneous pancreas transplant fine needle aspiration and needle core biopsies are useful and safe. Allen PD; Wilson TG; Grierson JM; Greenberg ML; Earl MJ; Stewart JH; Little JM; Chapman JR Transplant Proc; 1990 Apr; 22(2):663-4. PubMed ID: 2327013 [No Abstract] [Full Text] [Related]
17. Activation markers in late rejection of kidney allografts: fine needle aspiration biopsy analysis. Gonzalez-Posada JM; Garcia Castro C; Torres A; Lorenzo V; Losada M; Hernandez D; Maceira B; Salido E Transplant Proc; 1992 Feb; 24(1):65-6. PubMed ID: 1539347 [No Abstract] [Full Text] [Related]
18. Markers for pancreatic allograft rejection: comparison of serum anodal trypsinogen, serum amylase, serum creatinine and urinary amylase. Douzdjian V; Cooper JL; Abecassis MM; Corry RJ Clin Transplant; 1994 Apr; 8(2 Pt 1):79-82. PubMed ID: 7517225 [TBL] [Abstract][Full Text] [Related]
19. Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection. Elmer DS; Hathaway DK; Shokouh-Amiri HM; Hughes TA; Gaber LW; Gaber AO Transplant Proc; 1994 Apr; 26(2):536. PubMed ID: 7513456 [No Abstract] [Full Text] [Related]